Skip to Main Content

Paper Details

A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.
Gynecol Oncol
38
2017
Author NameAffiliation
Anthony FylesPrincess Margaret Cancer Centre/University Health Network, University of Toronto
Michael MilosevicPrincess Margaret Cancer Centre/University Health Network, University of Toronto
Lillian L SiuPrincess Margaret Cancer Centre/University Health Network, University of Toronto
  • 1 - 3

Datasets

Release 1.2